IRIS
CACCIOLA, Emma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.148
AS - Asia 5.831
EU - Europa 4.824
SA - Sud America 1.142
AF - Africa 229
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 10
Totale 24.194
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.608
SG - Singapore 3.405
CN - Cina 1.663
IE - Irlanda 1.325
UA - Ucraina 1.255
BR - Brasile 998
IT - Italia 740
RU - Federazione Russa 664
CA - Canada 471
VN - Vietnam 251
DE - Germania 184
GB - Regno Unito 130
SE - Svezia 130
KR - Corea 109
CI - Costa d'Avorio 105
IN - India 103
FR - Francia 59
NL - Olanda 58
CH - Svizzera 55
AR - Argentina 53
PL - Polonia 48
BD - Bangladesh 41
UZ - Uzbekistan 41
MX - Messico 40
FI - Finlandia 35
JP - Giappone 30
EC - Ecuador 28
TR - Turchia 27
ZA - Sudafrica 27
ES - Italia 20
AT - Austria 18
ID - Indonesia 18
GR - Grecia 17
CZ - Repubblica Ceca 16
EG - Egitto 16
IQ - Iraq 16
LB - Libano 16
NG - Nigeria 16
CO - Colombia 15
BJ - Benin 14
SN - Senegal 14
VE - Venezuela 14
BE - Belgio 13
MA - Marocco 13
RO - Romania 13
SA - Arabia Saudita 13
PE - Perù 12
TW - Taiwan 12
BG - Bulgaria 11
PK - Pakistan 11
PY - Paraguay 11
HK - Hong Kong 9
EU - Europa 8
IR - Iran 8
AU - Australia 7
JO - Giordania 7
TT - Trinidad e Tobago 7
IL - Israele 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
BY - Bielorussia 5
DZ - Algeria 5
JM - Giamaica 5
KW - Kuwait 5
KZ - Kazakistan 5
LT - Lituania 5
LY - Libia 5
PT - Portogallo 5
TN - Tunisia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
MY - Malesia 4
UY - Uruguay 4
CL - Cile 3
CR - Costa Rica 3
KG - Kirghizistan 3
MK - Macedonia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
ET - Etiopia 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GF - Guiana Francese 1
GY - Guiana 1
Totale 24.179
Salva come PNG Salva come JPEG
Città #
Dallas 2.530
Singapore 1.755
Dublin 1.321
Jacksonville 1.218
Santa Clara 1.167
Chandler 954
Ashburn 785
Boardman 526
Nanjing 422
Andover 367
Cambridge 360
Lawrence 353
Toronto 352
Hefei 247
Moscow 230
San Mateo 229
Des Moines 200
Chicago 190
Los Angeles 160
Wilmington 144
Catania 139
Beijing 138
Nanchang 123
Seoul 108
Abidjan 105
Hebei 98
Shenyang 95
Ho Chi Minh City 86
Saint Petersburg 84
São Paulo 82
Grafing 77
Ottawa 76
Jiaxing 75
Civitanova Marche 73
Buffalo 68
Changsha 68
Tianjin 66
New York 53
Council Bluffs 41
Hanoi 40
Rio de Janeiro 38
Warsaw 36
Bari 34
Dong Ket 30
Seattle 30
Bremen 28
Tokyo 26
Washington 26
Brooklyn 25
Milan 25
Norwalk 25
Redondo Beach 25
Kunming 24
Munich 24
Phoenix 24
San Francisco 24
Den Haag 22
Houston 21
Palermo 21
Pune 21
Amsterdam 20
Belo Horizonte 20
Boston 20
Montreal 20
Atlanta 19
Hangzhou 19
Liberty Lake 19
Quito 19
Ann Arbor 18
Johannesburg 18
Tashkent 18
Brasília 17
Curitiba 17
Abuja 16
Helsinki 16
Mumbai 15
Stockholm 15
Cotonou 14
Dakar 14
Jinan 14
Ningbo 14
The Dalles 14
Augusta 13
Brussels 13
Columbus 13
Kochi 13
Poplar 13
Porto Alegre 13
Manchester 12
Mexico City 12
Rome 12
Dhaka 11
Florence 11
Hanover 11
Redwood City 11
Secaucus 11
Charlotte 10
Istanbul 10
Lappeenranta 10
London 10
Totale 16.319
Salva come PNG Salva come JPEG
Nome #
Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothe- lium. 448
B-linfociti CALLA (CD10) positivi nella leucemia linfatica cronica. 172
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 163
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 160
Contributo delle piastrine reticolate alla generazione del fattore tessutale e del fattore di crescita trasformante-beta nella mielofibrosi primaria. Reticulated platelets contribution to tissue factor and transforming growth factor-beta generation in primary myelofibrosis. 151
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 139
Thrombotic risk stratification in patients with prefibrotic myelofibrosis 136
Activation of coaugulation and fibrinolysis in laparoscopic surgery 129
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea 123
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study 120
A cause for conversion of laparoscopic splenectomy: splenic candidiasis 116
Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values 112
A rare case of myeloid sarcoma presenting as anal fissure. 112
Surgical drain after open or laparoscopic splenectomy: is it needed or contraindicated? 110
Phase II randomized clinical trial comparing ropeginterferon versus phlebotomy in low-risk patients with polycythemia vera. Results of the pre-planned interim analysis. 110
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 109
Abnormal Erytropoietin serum levels in acute leukemia could have a role in the pathophysiology of disease. 108
Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction during sclerotherapy 108
Activation of coagulation anf fibrinolysis in laparoscopic surgery 107
D-dimer in the diagnostic work up of suspected pulmonary embolism: additional clinical value of PTP 106
Laparoscopic cholecystectomy in adult patients with sicklecell disease. 106
Alterations in ornithine decarboxylase and transglutaminase activities in lymphocytes from untrated patients with chronic lymphocytic leukemia. 106
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - Expression of acute phase reaction or index of va- scular endothelium damage? 106
Activation coagulation and fibrinolysis in laparoscopic surgery 106
Acute COPD exacerbations cause alteration of the endothelium-coagulative system 106
Activated factor XII and thrombin activable fibrynolysis inhibitor levels in essential thrombocythemia and polycythemia vera 101
All-trans retinoic (ATRA) induced apoptosis in pe- ripheral freshly isolated chronic myeloid leukemia cells. 100
Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms 100
Preoperative Predictive Factors of Conversions in Laparoscopic Splenectomies 99
Adverse outcome in non severe COVID-19: potential diagnostic coagulation tests 99
Angiogenesis in essential thrombocythemia: fibroblast growth factor-2 and vascular endothelial growth factor cross-talk 97
Abnormalities of haemostatic balance in essential thrombocythemia and polycythemia vera 97
Is it Still Reasonable to Raise Doubts on Laparoscopic Splenectomy? 97
Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale 95
Idiopathic intramural hematoma of the right colon. A case report and review of the literature. 95
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura 94
Acute lymphoblastic leukemia in elderly. 94
How to prevent intraoperative risks and complications in laparoscopic splenectomy 93
Laparoscopic splenectomy: a single center experience 91
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant 91
Laparoscopic splenectomy in patients under the age of eighteen. Experience in 18 cases. 89
Long-term results after splenectomy in adult idiopathic thrombocitopenic purpura: comparison between open and laparoscopic procedures 89
Abnormal production of interleukin (IL)-6 in essential thrombocythemia. 89
Hemocoagulative Modifications after Laparoscopic Surgery at Different Pneumoperitoneum Pressure Settings. 88
betaFibrinigen G-455-A gene polymorphism: is it a factor for aspirin platelet insensitivity in patients with essential thrombocythemia? 88
The use of surgical drains in laparoscopic splenectomies. Consideration on a large series of 117 consecutive cases 88
"In vitro" hyperresponsivity of diabetic platelets to "saturated" platelet-activating factor (PAF). 87
Late results after splenectomy in adult idiopathic thrombocytopenic purpura. 86
In vitro sensitivity of B-CLL cells to Fludarabine and Interferons 86
Laparoscopic cholecystectomuy in adult patients with sickle cell disease 86
Splanchnic vein thrombosis in JAK2V617F-positive patients with primary myelofibrosis and lower-risk IPSS. 85
I disordini dell'emostasi nelle emopatie maligne. 85
Modification of coaugulation and fibrinolysic parameters in laparoscopic cholecystectomy 85
Low dose of ARA-C in chronic myeloid leukemia in blastic transformation 84
The Antiphospholipid Syndrome 84
Evidence for an aincreased fatty acid utilization in platelets in diabetes mellitus: its correlation withn platelet hyperfunction 84
Alpha interferon as a first line therapy for angioimmunoblastic lympho- adenopathy. Possible value of DR+ cells in monitoring therapeutical re- sponse. 83
. Trombospondin plasma levels in beta tha- lassemia:sickle cell disease 83
Alteration of endothelium-coagulative system during COPD exacerbations 83
Chronic idiopatic trombocytopenic purpura: is there any factor to predict the response to splenectomy? 83
Essential thrombocythemia and fibroblast growth factor-2: role of anagrelide 83
All-trans retinoic acid might also induce apoptosis in freshly isolated chro- nic myeloid leukemia cells 82
The antiphospholipid syndrome in pregnancy: a review article 82
Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essentiial thrombocythemia: a preliminary report 82
Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia 82
Elevated plasma thrombopoietin levels and thrombosis in essential thrombocythemia: a preliminary report 81
Immunomodulating treatment in patients with aplastic anemia. 81
T-subset abnormalities in Thalassemia intermedia: Possible evidence for a Thymus functional deficiency. 81
Le anemie carenziali. 80
Trattamento preoperatorio con interleuchina-2 nel carcinoma colorettale. 80
Sopravvivenza libera da trombosi in 734 pazienti con trombocitemia essenziale (WHO 2016) stratificati secondo lo score "Revised International Prognostic Score for Thrombosis in Essential Thrombocythemia (R-IPSET-Th)". Studio del Regostro ItalianoTrombocitemie (RIT) 80
B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34 79
Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy 79
Splenic candidiasis : are perispelnic adhesions contraindications for laparoscopic splenectomy? 79
Acquired antithrombin III deficency in sickle cell disease/beta plus thalas- semia. 79
VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia. 78
Unusual onset of severe varicella in adult immunocompromised patients 78
Factor-VIII-rela- ted antigen and vasculitis. 78
B- chronic lymphocytic lekemia cells forming rosettes with sheep erythrocytes 78
PEG Intron treatment in 90 patients with assential thrombocithemia (ET) final report of a phase II study 77
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma 76
Persistent generalized lymphadenopathy (transfusion-related) in an HIV - seropositive heterosexual man with sckle-cell beta-tha- lassemia. 76
Role of FcR+ T-cells on the mechanism of the depressed polyclonal immunoglobulin synthesis in human mye- loma. 76
Laparoscopic splenectomy reduces the need of platelet transfusion in patients operated on for idiopathic thrombocytopenic purpura 76
Cessazione del fumo di sigaretta e riduzione dei livelli plasmatici di fattore di von Willebrand (vWF) 76
Il mitoxantrone in polichemioterapia associato allo schema CVP nel trat- tamento dei linfomi non hodgkin. 76
Cutaneous vasculitis in non Hodgkin's Lymphoma. 75
Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta Thalassemia: a pilot study. 75
Thymostimulin in aplastic anaemia. 75
Platelet factor 4, vascular endothelial growth factor and prothrombin fragment 1+2 levels in essential thrombocythemia treated with anagrelide 75
MECCANISMO DI ATTIVAZIONE PIASTRINICA NELLA TROMBOCITEMIA ESSENZIALE: RUOLO DEGLI ANTICORPI ANTI CELLULA ENDOTELIALE (AACE) 74
Low-dose cytarabine in myelodisplastic syndromes and acute leukemia: a comment 74
Portal vein thrombosis after laparoscopic splenectomy: report on personal experience 74
ECLAP Cooperative Group. A Randomized Trial. 73
Interleukin-8 levels in patients with essential thrombocythemia. 73
Surgical management of hereditary spherocytosis Current strategies 73
Retroperitoneal paraduodenal unicentric Castleman disease: case report and review of the literature 72
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis 72
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neolpasms 72
Serum overexpresion of interleukin-15 in patients with essential thrombocythemia: which significance? 72
Totale 9.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021758 0 0 0 0 0 26 198 13 287 10 163 61
2021/20222.657 346 387 21 30 429 5 394 92 282 5 63 603
2022/20233.474 365 93 28 229 348 652 4 576 971 29 115 64
2023/20241.666 81 110 73 86 65 160 160 355 17 40 230 289
2024/20255.265 38 716 369 170 1.183 404 110 201 517 689 313 555
2025/20267.057 704 595 2.641 779 2.097 241 0 0 0 0 0 0
Totale 24.678